MeSH tree: D02.065.950
Huntsman Cancer Institute at the University of Utah (the U) participated in a clinical trial that found that a new combination treatment plan helped people with recurring grade 3 astrocytoma, an aggressive form of brain cancer, ...
Dec 4, 2025
0
28
Sodium-glucose cotransporter-2 (SGLT-2) inhibitors are associated with a reduced risk for autoimmune rheumatic diseases compared with sulfonylureas among adults with type 2 diabetes, according to a study published online ...
Oct 23, 2025
0
13
Sodium-glucose cotransporter-2 (SGLT-2) inhibitors used to treat type 2 diabetes are associated with an 11% lower risk of autoimmune rheumatic diseases, such as rheumatoid arthritis and lupus, compared with another group ...
Oct 15, 2025
0
16
Liver cancer is the third-leading cause of cancer deaths worldwide, but a new study shows the solution to targeting this difficult-to-treat disease may already exist.
Oct 14, 2025
0
15
Approximately 9.5 million people globally live with type 1 diabetes, a chronic autoimmune disease where T cells from the body's immune system destroy insulin-producing cells in the pancreas, which are needed to control blood-sugar ...
Oct 2, 2025
0
28
Type 2 diabetes medications, such as sulfonylureas, have been a mainstay of treating the disease since they came on the market in the early 1950s. However, although they are one of the most common drugs for this condition, ...
Sep 25, 2025
0
87
A novel intervention aimed at helping adolescents with sickle cell disease maintain hydroxyurea treatment plans shows promising results at improving their quality of life, a new Columbia University School of Nursing study ...
Aug 27, 2025
0
14
Researchers from the School of Biomedical Sciences at the LKS Faculty of Medicine, the University of Hong Kong (HKUMed), have made a significant advancement that could reshape the treatment landscape for hepatocellular carcinoma ...
Aug 13, 2025
0
28
New research from investigators at Mass General Brigham suggests that a commonly used type 2 diabetes medication is linked to a higher rate of heart-related conditions compared to medications that hit other targets. The study ...
Jul 24, 2025
0
49
A new exploratory analysis of the HIMALAYA phase III trial involving patients with unresectable hepatocellular carcinoma (uHCC, an advanced liver cancer that could not be treated with surgery or other localized treatments) ...
Jul 22, 2025
0
14
